Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...

Equity benchmarks ended a four-day losing streak with modest gains on Tuesday, as easing CPI inflation lifted investor sentiment. Hopes of a potential rate cut spurred buying interest, pushing all NSE ...

A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.

Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...

Sun Pharma shares surged after a settlement with Incyte over Leqselvi, a drug for severe hair loss. The agreement includes a ...

India's equity indices ended a four-session decline, as inflation data came in lower than anticipated, increasing hopes for ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

Going forward, Aadhaar-based OTP verification has been made compulsory for Tatkal ticket bookings on IRCTC. This requirement ...

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

Sun Pharma shares rose nearly 2 per cent on Tuesday after the company launched Leqselvi, a new treatment for severe alopecia ...

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...